TrialClinical and translational science2024

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study.

Byung Hak Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.